Literature DB >> 33723313

Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use.

Adeel A Butt1,2,3,4, Peng Yan5, Shashi Kapadia6, Abdul-Badi Abou-Samra7, Naveed Z Janjua8,9, Said Ibrahim6.   

Abstract

Prescription opioid use (POU) is often a precursor to opioid use disorder (OUD) and subsequent consequences. Persons with chronic hepatitis C virus infection (CHC) may be at a higher risk of POU due to a higher comorbidity burden and social vulnerability factors. We sought to determine the burden of POU and associated risk factors among persons with CHC in the context of social vulnerability. We identified CHC persons and propensity-score matched HCV- controls in the electronically retrieved Cohort of HCV-Infected Veterans and determined the frequency of acute, episodic long-term and chronic long-term POU and the prevalence of social vulnerability factors among persons with POU. We used logistic regression analysis to determine factors associated with POU. Among 160,856 CHC and 160,856 propensity-score matched HCV-controls, acute POU was recorded in 38.4% and 38.0% (P = 0.01) respectively. Episodic long-term POU was recorded in 3.9% in each group (P = 0.5), while chronic long-term POU was recorded in 28.4% and 19.2% (P < 0.0001). CHC was associated with a higher risk of chronic long-term POU (OR 1.66, 95%CI 1.63, 1.69), but not with acute or episodic long-term POU. Black race, female sex and homelessness were associated with a higher risk of chronic long-term POU. Presence of ≥ 1 factor was associated with a higher risk of all POU patterns. Persons with CHC have more social vulnerability factors and a higher risk of chronic long-term POU. Presence of ≥ 1 social vulnerability factor is associated with a higher risk of POU. Downstream consequences of POU need further study.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33723313      PMCID: PMC7961056          DOI: 10.1038/s41598-021-85283-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  35 in total

1.  The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada.

Authors:  Julie Bruneau; Nelson Arruda; Geng Zang; Didier Jutras-Aswad; Élise Roy
Journal:  Addiction       Date:  2018-12-09       Impact factor: 6.526

2.  Viral hepatitis and other infectious diseases in a homeless population.

Authors:  Ramsey C Cheung; Aspasia K Hanson; Kalyani Maganti; Emmet B Keeffe; Suzanne M Matsui
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

Review 3.  Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection.

Authors:  Arpan Mohanty; Sarah Salameh; Adeel A Butt
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

4.  Associations between alcohol use and homelessness with healthcare utilization among human immunodeficiency virus-infected veterans.

Authors:  Adam J Gordon; Kathleen A McGinnis; Joseph Conigliaro; Maria C Rodriguez-Barradas; Linda Rabeneck; Amy C Justice
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

Review 5.  Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.

Authors:  Lisa I Iezzoni; Long H Ngo; Donglin Li; Richard G Roetzheim; Reed E Drews; Ellen P McCarthy
Journal:  Arch Phys Med Rehabil       Date:  2008-04       Impact factor: 3.966

6.  Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.

Authors:  Adeel Ajwad Butt; Peng Yan; Obaid S Shaikh; Vincent Lo Re; Abdul-Badi Abou-Samra; Kenneth E Sherman
Journal:  J Hepatol       Date:  2020-03-05       Impact factor: 25.083

7.  Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.

Authors:  J Y Chen; Y Ren; P Yan; M E Belina; R T Chung; A A Butt
Journal:  J Viral Hepat       Date:  2018-03-22       Impact factor: 3.728

8.  Racial disparities in blood pressure control and treatment differences in a Medicaid population, North Carolina, 2005-2006.

Authors:  Diane L Downie; Dorothee Schmid; Marcus G Plescia; Sara L Huston; Susan Bostrom; Angie Yow; William W Lawrence; C Annette DuBard
Journal:  Prev Chronic Dis       Date:  2011-04-15       Impact factor: 2.830

9.  Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System - United States, 2014-2017.

Authors:  Macarena C García; Charles M Heilig; Scott H Lee; Mark Faul; Gery Guy; Michael F Iademarco; Katherine Hempstead; Dorrie Raymond; Josh Gray
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-01-18       Impact factor: 17.586

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

Authors:  Nana Wilson; Mbabazi Kariisa; Puja Seth; Herschel Smith; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-20       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.